COMMUNIQUÉS West-GlobeNewswire

Valneva publie ses résultats financiers du premier trimestre 2024 et fait un point sur ses activités
07/05/2024
Valneva publie ses résultats financiers du premier trimestre 2024 et fait un point sur ses activités Principaux éléments financiers du premier trimestre Chiffre d’affaires total de 32,8 millions d’euros dont 32,1 [...]
argenx to Present at BofA Securities 2024 Health Care Conference
07/05/2024
May 7, 2024 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that [...]
Ultimovacs ASA Reports First Quarter 2024 Financial Results and Provides General Business Update
07/05/2024
Ultimovacs remains committed to continuing the clinical development strategy and exploring multiple pathways for UV1. The negative INITIUM results have had important consequences for the Company. Implemented cash [...]
Sandoz reports first quarter 2024 sales
07/05/2024
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Strong first quarter performance, with net sales [1] of USD 2.5 billion, up 6% in constant currencies (up 5% in USD) Biosimilar [...]
BioVersys Announces Expansion of Strategic Collaboration With GSK and Extension of Its Series C Round by CHF 12.3 Million
07/05/2024
Strategic collaboration with GSK expanded to accelerate clinical development of alpibectir for the treatment of tuberculosis GSK to participate in Series C Extension with equity investment Series C financing round [...]
Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering
07/05/2024
NEWTOWN, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for [...]
Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/05/2024
BEDFORD, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and [...]
Assure Reminds Stockholders To Vote For The Proposed Increase in Authorized Shares
06/05/2024
-- Of the Votes Received to Date, More than 95% Are Voting in Favor of the Increase -- More Votes Are Needed to Reach 50% of the Outstanding Shares Required for the Increase -- Every Vote Is Important to Avoid Delay in [...]
Inteleos to Host Roundtable on Advancing Maternal Health through Point-Of-Care-Ultrasound Certification
06/05/2024
Global healthcare certification leader convenes experts to discuss ultrasound training and certification as key strategy to reduce maternal mortality ROCKVILLE, Md., May 06, 2024 (GLOBE NEWSWIRE) -- Inteleos, a non- [...]
Viemed Healthcare Announces First Quarter 2024 Financial Results
06/05/2024
LAFAYETTE, La., May 06, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced [...]
Precipio Secures a short-term $500K Credit Facility
06/05/2024
Loan will supplement any temporary cashflow deficit related to cash collections delay due to Change Healthcare cybersecurity attack NEW HAVEN, Conn., May 06, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company [...]
T2 Biosystems Announces First Quarter 2024 Financial Results
06/05/2024
Achieved double-digit growth in sepsis product revenue and reduced debt by approximately 80% compared to the prior year period LEXINGTON, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “ [...]
T2 Biosystems Announces Commercial Expansion Through Middle East Distributor
06/05/2024
Filed Pursuant to Rule 433 Issuer Free Writing Prospectus dated May 6, 2024 Relating to Preliminary Prospectus dated May 6, 2024 Registration No. 333-278866 LEXINGTON, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- T2 [...]
Aptose to Report First Quarter 2024 Financial Results and Provide Clinical Strategy Update on Tuesday, May 14, 2024
06/05/2024
SAN DIEGO and TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical- stage precision oncology company developing highly differentiated oral targeted agents to treat [...]
Day One Reports First Quarter 2024 Financial Results and Corporate Progress
06/05/2024
OJEMDA™ (tovorafenib) launch underway following U.S. FDA accelerated approval for relapsed or refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG) First prescriptions received in the U.S. BRISBANE, Calif., May 06, [...]
Immuneering Recognizes Melanoma Awareness Month
06/05/2024
- Two clinical stage product candidates in development for the treatment of melanoma - - RAS mutant melanoma represents one of five arms in the company’s ongoing Phase 2a clinical study of IMM-1-104 - - Melanoma also [...]
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
06/05/2024
(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) PARIS, 06 mai 2024 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Growth ISIN code: FR0010425595 Date Nombre total d’actions composant le [...]
Monthly information on share capital and company voting rights
06/05/2024
(Article 223-16 of General Regulation of the French financial markets authority) PARIS, May 06, 2024 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 Date Total number of shares in the capital [...]
T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into Equity
06/05/2024
Strengthens balance sheet by reducing total debt by approximately 80% over the past year Filed Pursuant to Rule 433 Issuer Free Writing Prospectus dated May 6, 2024 Relating to Preliminary Prospectus dated May 6, 2024 [...]

Pages